Furethidine
Подписчиков: 0, рейтинг: 0
| Clinical data | |
|---|---|
| Other names | ethyl 4-phenyl-1-(2-tetrahydrofurfuryloxyethyl)piperidine-4-carboxylate |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank |
|
| ChemSpider |
|
| UNII | |
| ChEMBL | |
| ECHA InfoCard | 100.017.451 |
| Chemical and physical data | |
| Formula | C21H31NO4 |
| Molar mass | 361.482 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Furethidine is a 4-phenylpiperidine derivative that is related to the clinically used opioid analgesic drug pethidine (meperidine), but with around 25x higher potency. According to another source, Furethidine is 500/30 = 16.7 x the potency of pethidine (table VII).
Furethidine is not currently used in medicine and is a Class A/Schedule I drug which is controlled under UN drug conventions. It has similar effects to other opioid derivatives, such as analgesia, sedation, nausea and respiratory depression. In the United States it is a Schedule I Narcotic controlled substance with the ACSCN of 9626.